These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1277 related items for PubMed ID: 20133981

  • 21. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
    Smeenk RM, Verwaal VJ, Zoetmulder FA.
    Eur J Surg Oncol; 2006 Mar; 32(2):186-90. PubMed ID: 16303281
    [Abstract] [Full Text] [Related]

  • 22. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.
    Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
    [Abstract] [Full Text] [Related]

  • 23. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FA.
    Br J Surg; 2004 Jun; 91(6):739-46. PubMed ID: 15164445
    [Abstract] [Full Text] [Related]

  • 24. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [Abstract] [Full Text] [Related]

  • 25. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.
    Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL.
    Ann Surg Oncol; 2009 Jul; 16(7):1903-11. PubMed ID: 19387742
    [Abstract] [Full Text] [Related]

  • 26. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
    Spiliotis J, Tentes AA, Vaxevanidou A, Korakianitis OS, Rogdakis A, Mirelis CG, Datsis AC, Kekelos S.
    J BUON; 2008 Jul; 13(2):205-10. PubMed ID: 18555466
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis.
    Pelz JO, Stojadinovic A, Nissan A, Hohenberger W, Esquivel J.
    J Surg Oncol; 2009 Jan 01; 99(1):9-15. PubMed ID: 18937291
    [Abstract] [Full Text] [Related]

  • 29. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A.
    Ann Surg Oncol; 2012 Jan 01; 19(1):110-4. PubMed ID: 21701929
    [Abstract] [Full Text] [Related]

  • 30. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
    Pelz JO, Doerfer J, Dimmler A, Hohenberger W, Meyer T.
    BMC Cancer; 2006 Jun 22; 6():162. PubMed ID: 16792796
    [Abstract] [Full Text] [Related]

  • 31. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma.
    Piso P, Bektas H, Werner U, Schlitt HJ, Kubicka S, Bornscheuer A, Manns M, Klempnauer J.
    Eur J Surg Oncol; 2001 Apr 22; 27(3):286-90. PubMed ID: 11373107
    [Abstract] [Full Text] [Related]

  • 32. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD, Chu F, Links M, Kam PC, Glenn D, Morris DL.
    Eur J Surg Oncol; 2006 Dec 22; 32(10):1119-24. PubMed ID: 16887321
    [Abstract] [Full Text] [Related]

  • 33. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.
    Ann Surg Oncol; 2009 Feb 22; 16(2):463-72. PubMed ID: 19082859
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis.
    Marcotte E, Sideris L, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Dubé P.
    Ann Surg Oncol; 2008 Oct 22; 15(10):2701-8. PubMed ID: 18654822
    [Abstract] [Full Text] [Related]

  • 38. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
    Yang XJ, Li Y, Yonemura Y.
    J Surg Oncol; 2010 May 01; 101(6):457-64. PubMed ID: 20401915
    [Abstract] [Full Text] [Related]

  • 39. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
    Pocard M, Boige V.
    Bull Cancer; 2005 Feb 01; 92(2):151-4. PubMed ID: 15749644
    [Abstract] [Full Text] [Related]

  • 40. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M.
    Ann Surg; 2009 Feb 01; 249(2):243-9. PubMed ID: 19212177
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 64.